A PHASE IB PHARMACOLOGICAL STUDY OF SORAFENIB IN COMBINATION WITH GEMCITABINE/CISPLATIN IN PATIENTS WITH REFRACTORY SOLID TUMORS INCLUDING NON-SMALL CELL LUNG CANCER

被引：0
|
作者：
Schultheis, B. [1 ]
Kummer, G. [1 ]
Zeth, M. [1 ]
Brendel, E. [2 ]
Kornacker, M. [2 ]
Strumberg, D. [1 ]
机构：
[1] Marienhosp Herne, Herne, Germany
[2] Bayer HealthCare, Wuppertal, Germany
来源：
ANNALS OF ONCOLOGY | 2010年 / 21卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：155 / 155
页数：1
相关论文
共 50 条
  • [1] Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
    Schultheis, B.
    Kummer, G.
    Zeth, M.
    Brendel, E.
    Xia, C.
    Kornacker, M.
    Strumberg, D.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 69 (02) : 333 - 339
  • [2] Phase IB study of sorafenib in combination with gemcitabine and cisplatin in patients with refractory solid tumors
    B. Schultheis
    G. Kummer
    M. Zeth
    E. Brendel
    C. Xia
    M. Kornacker
    D. Strumberg
    Cancer Chemotherapy and Pharmacology, 2012, 69 : 333 - 339
  • [3] A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer
    Ernest Nadal
    Mansoor Saleh
    Santiago Ponce Aix
    Maria Ochoa-de-Olza
    Sandip Pravin Patel
    Scott Antonia
    Yumin Zhao
    Ivelina Gueorguieva
    Michael Man
    Shawn T. Estrem
    Jiangang Liu
    Emin Avsar
    Wen Hong Lin
    Karim A. Benhadji
    Leena Gandhi
    Susan C. Guba
    Inmaculada Ales Diaz
    BMC Cancer, 23
  • [4] A phase Ib/II study of galunisertib in combination with nivolumab in solid tumors and non-small cell lung cancer
    Nadal, Ernest
    Saleh, Mansoor
    Aix, Santiago Ponce
    Ochoa-de-Olza, Maria
    Patel, Sandip Pravin
    Antonia, Scott
    Zhao, Yumin
    Gueorguieva, Ivelina
    Man, Michael
    Estrem, Shawn T.
    Liu, Jiangang
    Avsar, Emin
    Lin, Wen Hong
    Benhadji, Karim A.
    Gandhi, Leena
    Guba, Susan C.
    Diaz, Inmaculada Ales
    BMC CANCER, 2023, 23 (01)
  • [5] A phase II study of gemcitabine with cisplatin in patients with non-small cell lung cancer
    Abratt, RP
    Bezwoda, WR
    Goedhals, L
    Hacking, DJ
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1086 - 1086
  • [6] Gemcitabine-cisplatin combination in non-small cell lung cancer (NSCLC). A phase II study
    Crino, L
    Seagliotti, G
    Marangolo, M
    Figoli, F
    Clerici, M
    DeMarinis, F
    Salvati, F
    Cruciani, G
    Dogliotti, L
    Cocconi, G
    Paccagnella, A
    Adamo, V
    Incoronato, P
    Scarcella, L
    Mosconi, AM
    Tonato, M
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1064 - 1064
  • [7] Phase II study of Gemcitabine in combination with cisplatin and ifosfamide in advanced non-small cell lung cancer
    Mohedano, N
    Medina, MB
    Sanchez, P
    Jaen, A
    Gonzalez, E
    Porras, I
    Fernandez, M
    Lozano, A
    ANNALS OF ONCOLOGY, 1998, 9 : 90 - 90
  • [8] Phase I trial of sorafenib in combination with gefitinib in patients with refractory or recurrent non-small cell lung cancer
    Adjei, Alex A.
    Molina, Julian R.
    Mandrekar, Sumithra J.
    Marks, Randolph
    Reid, Joel R.
    Croghan, Gary
    Hanson, Lorelei J.
    Jett, James R.
    Xia, Chenghua
    Lathia, Chetan
    Simantov, Ronit
    CLINICAL CANCER RESEARCH, 2007, 13 (09) : 2684 - 2691
  • [9] Combination of gemcitabine and cisplatin for advanced non-small cell lung cancer: a phase II study with emphasis on scheduling
    Huisman, C
    Giaccone, G
    van Groeningen, CJ
    Sutedja, G
    Postmus, PE
    Smit, EF
    LUNG CANCER, 2001, 33 (2-3) : 267 - 275
  • [10] Gemcitabine plus cisplatin in non-small cell lung cancer: A Phase II study
    Sandler, A
    Ansari, R
    McClean, J
    Fisher, W
    Dorr, FA
    Einhorn, LH
    EUROPEAN JOURNAL OF CANCER, 1995, 31A : 1079 - 1079
12345